Advertisement
Research Article

Elimination and Eradication of Neglected Tropical Diseases with Mass Drug Administrations: A Survey of Experts

  • Jeremy D. Keenan mail,

    jeremy.keenan@ucsf.edu

    Affiliations: Francis I Proctor Foundation, University of California, San Francisco, San Francisco, California, United States of America, Department of Ophthalmology, University of California, San Francisco, San Francisco, California, United States of America

    X
  • Peter J. Hotez,

    Affiliations: Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, Texas, United States of America, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America, Sabin Vaccine Institute, Washington, D.C., United States of America

    X
  • Abdou Amza,

    Affiliations: Université Abdou Moumouni de Niamey, Niamey, Niger, Programme National de Lutte Contre la Cécité, Niamey, Niger

    X
  • Nicole E. Stoller,

    Affiliation: Francis I Proctor Foundation, University of California, San Francisco, San Francisco, California, United States of America

    X
  • Bruce D. Gaynor,

    Affiliations: Francis I Proctor Foundation, University of California, San Francisco, San Francisco, California, United States of America, Department of Ophthalmology, University of California, San Francisco, San Francisco, California, United States of America

    X
  • Travis C. Porco,

    Affiliations: Francis I Proctor Foundation, University of California, San Francisco, San Francisco, California, United States of America, Department of Ophthalmology, University of California, San Francisco, San Francisco, California, United States of America, Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, California, United States of America

    X
  • Thomas M. Lietman

    Affiliations: Francis I Proctor Foundation, University of California, San Francisco, San Francisco, California, United States of America, Department of Ophthalmology, University of California, San Francisco, San Francisco, California, United States of America, Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, California, United States of America, Institute for Global Health, University of California, San Francisco, San Francisco, California, United States of America

    X
  • Published: December 05, 2013
  • DOI: 10.1371/journal.pntd.0002562

About the Authors

Jeremy D. Keenan, Nicole E. Stoller, Bruce D. Gaynor, Travis C. Porco, Thomas M. Lietman
Francis I Proctor Foundation, University of California, San Francisco, San Francisco, California, United States of America
Jeremy D. Keenan, Bruce D. Gaynor, Travis C. Porco, Thomas M. Lietman
Department of Ophthalmology, University of California, San Francisco, San Francisco, California, United States of America
Peter J. Hotez
Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, Texas, United States of America
Peter J. Hotez
National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America
Peter J. Hotez
Sabin Vaccine Institute, Washington, D.C., United States of America
Abdou Amza
Université Abdou Moumouni de Niamey, Niamey, Niger
Abdou Amza
Programme National de Lutte Contre la Cécité, Niamey, Niger
Travis C. Porco, Thomas M. Lietman
Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, California, United States of America
Thomas M. Lietman
Institute for Global Health, University of California, San Francisco, San Francisco, California, United States of America

Corresponding Author

Email: jeremy.keenan@ucsf.edu

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: JDK PJH AA NES BDG TCP TML. Performed the experiments: JDK NES TML. Analyzed the data: JDK TCP TML. Wrote the paper: JDK PJH AA NES BDG TCP TML.